Study of LY4178256 in Healthy Volunteers
This is a Phase 1 study testing a new medicine called LY4178256. It will check how the drug is processed by the body and its safety in healthy volunteers. The results help doctors understand how to dose the drug in future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in generally good health, with no major medical conditions like heart disease, liver problems, or kidney issues.
- Your body mass index (BMI) should be between 19 and 32.
- If you're male, you must agree to use effective birth control during the study. If you're female, you must not be able to become pregnant (e.g., postmenopausal or surgically sterile).
- You cannot have abnormal blood pressure, heart rhythm problems, or a history of drug abuse.
- Your blood tests must show normal liver and kidney function, and no issues with anemia or iron deficiency.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This study tests a new drug called LY5625575 in healthy people and in people with inflammation (measured by a blood test called C-reactive protein). The goal is to see if the drug is safe and how the body processes it.
This study tests a new drug called CLYM116 in healthy adults to see how safe it is and how the body processes it. It may help researchers learn more before testing it in people with certain medical conditions.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.